[
    [
        {
            "time": "2021-Q3",
            "original_text": "云南白药三季度净利腰斩，这次炒股也不灵了，亏了15亿 盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "净利下降",
                    "炒股亏损",
                    "公允价值变动损失"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药三季度净利腰斩，这次炒股也不灵了，亏了15亿 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-Q3",
            "original_text": "云南白药前三季净利首次下降，炒股浮亏15亿，千亿元白马怎么了？ 盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "净利下滑",
                    "炒股亏损",
                    "公允价值变动损失"
                ],
                "sentiment_score": -0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药前三季净利首次下降，炒股浮亏15亿，千亿元白马怎么了？ 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-Q3",
            "original_text": "云南白药：前三季度净利润同比下降42.38% 盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "净利下降",
                    "同比减少"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药：前三季度净利润同比下降42.38% 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-Q3",
            "original_text": "云南白药：第三季度净利润同比下降63.94%，研发费用创新高 盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "单季净利下降",
                    "研发费用增加"
                ],
                "sentiment_score": -0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药：第三季度净利润同比下降63.94%，研发费用创新高 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-Q3",
            "original_text": "云南白药：前三季度净利润同比下降42.38%，公允价值变动收益亏超15亿",
            "features": {
                "keywords": [
                    "云南白药",
                    "净利下降",
                    "公允价值变动损失"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药：前三季度净利润同比下降42.38%，公允价值变动收益亏超15亿",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]